PubRank

Sharyn N Lewin

Author PubWeight™ 65.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA 2013 4.67
2 Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. J Clin Oncol 2012 2.59
3 Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer. Am J Obstet Gynecol 2011 2.19
4 Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol 2013 2.05
5 Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol 2012 1.98
6 Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol 2011 1.86
7 Trends in hospital volume and patterns of referral for women with gynecologic cancers. Obstet Gynecol 2013 1.72
8 Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecol Oncol 2011 1.66
9 Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications. Obstet Gynecol 2012 1.58
10 Regionalization of care for obstetric hemorrhage and its effect on maternal mortality. Obstet Gynecol 2010 1.56
11 The effect of surgeon volume on outcomes and resource use for vaginal hysterectomy. Obstet Gynecol 2010 1.56
12 Scientific evidence underlying the American College of Obstetricians and Gynecologists' practice bulletins. Obstet Gynecol 2011 1.55
13 Variation in ovarian conservation in women undergoing hysterectomy for benign indications. Obstet Gynecol 2013 1.46
14 Quality of perioperative venous thromboembolism prophylaxis in gynecologic surgery. Obstet Gynecol 2011 1.21
15 Natural history and outcome of mucinous carcinoma of the ovary. Am J Obstet Gynecol 2011 1.16
16 Effect of surgical volume on morbidity and mortality of abdominal hysterectomy for endometrial cancer. Obstet Gynecol 2011 1.14
17 Failure to rescue as a source of variation in hospital mortality for ovarian cancer. J Clin Oncol 2012 1.14
18 Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes. JAMA Intern Med 2013 1.13
19 Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer. Obstet Gynecol 2012 1.09
20 Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome. Gynecol Oncol 2013 1.03
21 Use of guideline-based antibiotic prophylaxis in women undergoing gynecologic surgery. Obstet Gynecol 2013 1.03
22 Carcinosarcoma of the ovary-a case series. Gynecol Oncol 2005 1.03
23 Feasibility and economic impact of same-day discharge for women who undergo laparoscopic hysterectomy. Am J Obstet Gynecol 2012 1.01
24 Therapeutic role of lymphadenectomy for cervical cancer. Cancer 2010 1.00
25 Sarcoma of the cervix: natural history and outcomes. Gynecol Oncol 2010 1.00
26 Morbidity and mortality of peripartum hysterectomy. Obstet Gynecol 2010 1.00
27 Patterns of care and treatment outcomes for elderly women with cervical cancer. Cancer 2011 1.00
28 The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals. Am J Obstet Gynecol 2012 0.97
29 Influence of surgical volume on outcome for laparoscopic hysterectomy for endometrial cancer. Ann Surg Oncol 2011 0.96
30 Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access. Obstet Gynecol 2010 0.95
31 Adherence to evidence-based guidelines for preoperative testing in women undergoing gynecologic surgery. Obstet Gynecol 2010 0.94
32 Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer. Gynecol Oncol 2013 0.94
33 Endometrial cancer in the oldest old: Tumor characteristics, patterns of care, and outcome. Gynecol Oncol 2011 0.93
34 The influence of surgical volume on morbidity and mortality of radical hysterectomy for cervical cancer. Am J Obstet Gynecol 2011 0.93
35 Pediatric radical abdominal trachelectomy for anaplastic embryonal rhabdomyosarcoma of the uterine cervix: an alternative to radical hysterectomy. J Pediatr Surg 2009 0.93
36 Quality of venous thromboembolism prophylaxis in patients undergoing oncologic surgery. Ann Surg 2011 0.93
37 Comparative effectiveness of minimally invasive and abdominal radical hysterectomy for cervical cancer. Gynecol Oncol 2012 0.92
38 Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy. Obstet Gynecol 2011 0.92
39 Long-term outcome and natural history of uterine adenosarcomas. Gynecol Oncol 2010 0.91
40 Patterns of use of hemostatic agents in patients undergoing major surgery. J Surg Res 2013 0.88
41 Acceptance and compliance with postpartum human papillomavirus vaccination. Obstet Gynecol 2012 0.88
42 Contemporary clinical management of endometrial cancer. Obstet Gynecol Int 2013 0.86
43 Morbidity and mortality of surgery for endometrial cancer in the oldest old. Am J Obstet Gynecol 2011 0.86
44 An economic analysis of robotically assisted hysterectomy. Obstet Gynecol 2014 0.85
45 Recurrent vulvar carcinoma in pregnancy. Gynecol Oncol 2004 0.83
46 Microinvasive adenocarcinoma of the cervix. Am J Obstet Gynecol 2011 0.82
47 Neoadjuvant bevacizumab in a granulosa cell tumor of the ovary: a case report. Anticancer Res 2010 0.81
48 Risk and predictors of malignancy in women with endometrial polyps. Ann Surg Oncol 2011 0.81
49 Failure to rescue after major gynecologic surgery. Am J Obstet Gynecol 2013 0.81
50 Quantitative X-ray computed tomography peritoneography in malignant peritoneal mesothelioma patients receiving intraperitoneal chemotherapy. Ann Surg Oncol 2013 0.80
51 Comparison of the prognostic significance of uterine factors and nodal status for endometrial cancer. Am J Obstet Gynecol 2011 0.80
52 Patterns of care for locally advanced vulvar cancer. Am J Obstet Gynecol 2013 0.80
53 Prognostic significance of mucinous differentiation of endometrioid adenocarcinoma of the endometrium. Cancer Invest 2013 0.79
54 Paclitaxel poliglumex for ovarian cancer. Expert Opin Investig Drugs 2011 0.78
55 Utilization and safety of sodium hyaluronate-carboxymethylcellulose adhesion barrier. Dis Colon Rectum 2013 0.77
56 Cytologic findings after fertility-sparing radical trachelectomy. Cancer 2008 0.76
57 Body surface area predicts plasma oxaliplatin and pharmacokinetic advantage in hyperthermic intraoperative intraperitoneal chemotherapy. Ann Surg Oncol 2013 0.76
58 Access to conservative surgical therapy for adolescents with benign ovarian masses. Obstet Gynecol 2012 0.75
59 Hemolytic uremic syndrome presenting after treatment of endodermal sinus tumor. Obstet Gynecol 2004 0.75
60 Safety of conservative management of ovarian masses during pregnancy. J Reprod Med 2013 0.75